Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Cancer Technologies, Inc. — Predicate Candidate Screening
4 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K883220 | EXTRAVAKIT FOR RADIOLOGICAL APPLICATIONS | Cancer Technologies, Inc. | 1988-10-20 | 83 | 0 |
| K883242 | EXTRAVAKIT FOR DIMETHYLSULFOXIDE (DMSO) | Cancer Technologies, Inc. | 1988-10-12 | 71 | 0 |
| K874807 | EXTRAVAKIT | Cancer Technologies, Inc. | 1988-02-04 | 76 | 0 |
| K874352 | TUMORIMETER | Cancer Technologies, Inc. | 1987-11-23 | 31 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda